Abeona Therapeutics Inc. (ABEO)
Biotechnology · Healthcare · $329M
Intrinsic Value (Consensus)
$37.06
Current Price
$5.79
Margin of Safety
+300%
300% Below Intrinsic Value
Value: $37
Price: $6
Valuation Model Estimates
Current Price: $5.79
DCF (Discounted Cash Flow)
$48.14
Graham Number
$7.39
Earnings Power Value
$7.03
Relative Value (P/E)
$25.98
Dividend Discount Model
Not applicable
—
Consensus Value
$37.06
Model Assumptions
Discount Rate
10.3%
Growth Rate
30.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
A
86
Profitability
25/25
Strength
14/25
Valuation
22/25
Growth
25/25
Financial Health Signals
Negative free cash flow — company is burning cash
Strong profitability — ROE of 45% (above 20% is excellent)
Low debt — conservative balance sheet
Strong earnings growth (30% YoY)
Key Financials
- EPS (TTM)
- $0.87
- EPS (Forward)
- $1.13
- Book Value
- $2.80
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 44.7%
- Debt/Equity
- 13%
- Revenue Growth
- 66.3%
- Earnings Growth
- 30.0%
- Dividend Yield
- N/A
- Beta
- 1.33
Similar Stocks (Healthcare)
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
NVAXNOVAVAX INC
$36.38+295.4%
Data last updated: 2026-06-21
Source: Yahoo Finance